Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H16ClNO4 |
Molecular Weight | 357.788 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=C1)C(C(=O)C3=CC=C(Cl)C=C3)=C(C)N2CC(O)=O
InChI
InChIKey=DGMZLCLHHVYDIS-UHFFFAOYSA-N
InChI=1S/C19H16ClNO4/c1-11-18(19(24)12-3-5-13(20)6-4-12)15-8-7-14(25-2)9-16(15)21(11)10-17(22)23/h3-9H,10H2,1-2H3,(H,22,23)
DescriptionSources: http://www.trc-canada.com/product-detail/?C586995Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/2940571
https://www.ncbi.nlm.nih.gov/pubmed/6991549
http://www.biomedcentral.com/content/supplementary/s12916-014-0262-7-s2.pdf
Sources: http://www.trc-canada.com/product-detail/?C586995
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/2940571
https://www.ncbi.nlm.nih.gov/pubmed/6991549
http://www.biomedcentral.com/content/supplementary/s12916-014-0262-7-s2.pdf
The NSAID clometacin is an indometacin derivative. Clometacin is an analgesic drug that binds to human serum albumin (HSA) and inhibits the binding of indomethacin, warfarin, clofibrate and salicylic acid to HSA. Clometacin (DUPERAN) was approved in France in 1977. All preparations containing clometacin were withdrawn in 1987 due to their hepatotoxicity.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4334 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1900533 |
200.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6991549 |
Palliative | DUPERAN Approved UsePain Launch Date1976 |
PubMed
Title | Date | PubMed |
---|---|---|
[Liver damage following clomethacin treatment. 6 cases, including 2 deaths (author's transl)]. | 1981 Sep 19 |
|
Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. | 1985 Sep-Oct |
|
Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems. | 2006 Aug |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6991549
clometacin (450 to 600 mg) daily
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20732071
Clometacin at a concentration of 6 x 10(-4) M induced hepatitis in normal human hepatocytes culture
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
33176
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
DTXSID7048827
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
C77348
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
m1080
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
247-271-3
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
L9M34YK25C
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
CHEMBL13376
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
698
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
SUB06718MIG
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
3041
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
100000084543
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
25803-14-9
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY | |||
|
C017136
Created by
admin on Fri Dec 15 16:39:30 GMT 2023 , Edited by admin on Fri Dec 15 16:39:30 GMT 2023
|
PRIMARY |
ACTIVE MOIETY